HOWL: Werewolf Therapeutics, Inc. Stock

by  •  • Comments Off on HOWL: Werewolf Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 263.55
Enterprise Value ($M) 168.53
Book Value ($M) 111.37
Book Value / Share 2.57
Price / Book 2.37
NCAV ($M) 74.91
NCAV / Share 1.73
Price / NCAV 3.52

Profitability (mra)
Return on Invested Capital (ROIC) -0.25
Return on Assets (ROA) -0.21
Return on Equity (ROE) -0.34

Liquidity (mrq)
Quick Ratio 7.14
Current Ratio 7.14

Balance Sheet (mrq) ($M)
Current Assets 138.37
Assets 174.83
Liabilities 63.46
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 19.94
Operating Income -40.50
Net Income -37.37

Cash Flow Statement (mra) ($M)
Cash From Operations -32.61
Cash from Investing -0.77
Cash from Financing 58.43

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A PFM Health Sciences, LP 9.60
02-14 13D/A Ra Capital Management, L.p. 15.20 0.32
02-13 13G Bank Of America Corp /de/ 5.80
02-12 13G/A Rubric Capital Management LP 5.35 5.45
12-21 13G Adage Capital Partners Gp, L.l.c. 8.38

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 33,010 131,431 25.12
2024-05-02 8,953 32,070 27.92
2024-05-01 19,985 51,590 38.74
2024-04-30 24,999 42,639 58.63
2024-04-29 15,309 45,926 33.33

(click for more detail)

Similar Companies
GTHX – G1 Therapeutics, Inc. HALO – Halozyme Therapeutics, Inc.
HLVX – HilleVax, Inc. HUMA – Humacyte, Inc.
IBRX – ImmunityBio, Inc.


Financial data and stock pages provided by
Fintel.io